Cronos Group Inc
Produces and sells cannabis and hemp-based products.
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying Cronos Group's stock, with a target price indicating room for growth.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring CRON
Vice Arbitrage
Get exposure to companies leading the transformation of once-prohibited activities into booming legal industries. These carefully selected stocks represent market leaders capitalizing on shifting regulations in sports betting, cannabis, and more, unlocking tremendous growth potential.
Published: June 17, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Growth potential
Product innovation and expanding adult‑use markets could support growth, though outcomes depend on regulation, competition and execution.
Strategic partnerships
Partnerships and investment can help access distribution and capital, but rely on counterparties and favourable market conditions.
Volatile returns
Cannabis stocks are often volatile and sensitive to regulatory shifts and capital needs; investors should expect price swings and possible losses.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Eli Lilly and Company
Eli Lilly & Co is a global pharmaceutical company that develops, manufactures and markets human prescription drugs.
Johnson & Johnson
Johnson & Johnson is a multinational conglomerate pharmaceutical, medical devices, and consumer packaged goods company.
AbbVie Inc.
Abbvie is a research-based biopharmaceutical company that develops and markets advanced therapies to address complex medical conditions.
